Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)

European Archives of Oto-Rhino-Laryngology

Volumn 266, Issue 8, 2009, Pages 1291-1300

  Dietz, Andreas ^a   Rudat, Volker ^b   Dreyhaupt, Jens ^c   Pritsch, Maria ^c   Hoppe, Florian ^d   Hagen, Rudolph ^e   Pfreundner, Leo ^e   Schröder, Ursula ^f   Eckel, Hans ^g   Hess, Markus ^h   Schröder, Michael ⁱ   Schneider, Petra ⁱ   Jens, Bünzel ^j   Zenner, Hans P ^k   Werner, Jochen A ^l   Engenhardt Cabillic, Rita ^l   Vanselow, Bernhard ^m   Plinkert, Peter ^c   Niewald, Marcus ⁿ   Kuhnt, Thomas ^o   Budach, Wilfried ^p   Flentje, Michael ^e   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

^b SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d KLINIKUM OLDENBURG   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY OF LÜBECK   (Germany)

^g GENERAL HOSPITAL KLAGENFURT   (Austria)

^h UNIVERSITY OF HAMBURG   (Germany)

ⁱ KLINIKUM KASSEL   (Germany)

^j Sudharz Hospital   (Germany)

^k UNIVERSITY OF TÜBINGEN   (Germany)

^l PHILIPPS UNIVERSITY MARBURG   (Germany)

^m StVincentius ^*  (Germany)

ⁿ SAARLAND UNIVERSITY   (Germany)

^o MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^p HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

Head and neck; Hypopharynx cancer; Induction chemo; Larynx; Organ preservation

Indexed keywords

CISPLATIN; CLEMASTINE; DEXAMETHASONE; GRANISETRON; PACLITAXEL; RANITIDINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DYSPHAGIA; FEMALE; HOARSENESS; HUMAN; HYPOPHARYNX CARCINOMA; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX EDEMA; LARYNX PAIN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NECK DISSECTION; NEUROPATHY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; SALVAGE THERAPY; SIDE EFFECT; SKIN FIBROSIS; SKIN FISTULA; SKIN PIGMENTATION; TRACHEOTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67650938351     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-008-0846-y     Document Type: Article

References (26)

1. DJ Adelstein M Leblanc 2006 Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? J Clin Oncol 24 17 2624 2628 (Pubitemid 46622083)
2. DJ Adelstein JP Saxton P Lavertu L Tuason BG Wood JR Wanamaker I Eliachar M Strome MA Van Kirk 1997 A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy aline in resectable stage III and IV squamous cell head and neck cancer: preliminary results, chemoradiotherapy versus radiotherapy Head Neck 19 567 575 (Pubitemid 27407310)
3. American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, Clayman GL, Fisher SG, Forastiere AA, Harrison LB, Lefebvre JL, Leupold N, List MA, O'Malley BO, Patel S, Posner MR, Schwartz MA, Wolf GT (2007) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 25(6):735-736
4. DF Brasnu DM Hartl 2008 The Laryngologist in organ preservation for laryngeal cancer, letter to the editor Laryngoscope 118 4 759 760
5. Calais G, Pointreau Y, Alfonsi M, Sire C, Tuchais C, Tortochaux J, Bourhis J, Guerrif S, Garaud P (2006) Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement) 5506
6. F Denis P Garaud E Bardet 2003 Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced stage oropharynx carcinoma: comparison of the LENT/SOMA, RTOG/EORTC, and the NCI-CTC scoring sytems Int J Radiat Oncol Biol Phys 55 93 98 (Pubitemid 36020347)
7. A Dietz J Nollert H Eckel P Volling M Schroder S Staar C Conradt B Helmke R Dollner RP Muller M Wannenmacher H Weidauer V Rudat 2002 Organ preservation in advanced laryngeal and hypopharyngeal carcinoma by primary radiochemotherapy. Results of a multicenter phase II study HNO 50 146 154 (Pubitemid 36062189)
8. A Dietz V Rudat J Nollert M Helbig B Vanselow H Weidauer 1998 Chronic laryngeal edema as a late reaction to radiochemotherapy HNO 46 8 731 738 (Pubitemid 28396932)
9. AA Forastiere H Goepfert M Maor TF Pajak R Weber W Morrison B Glisson A Trotti JA Ridge C Chao G Peters DJ Lee A Leaf J Ensley J Cooper 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 2098 (Pubitemid 37464533)
10. AA Forastiere A Trotti DG Pfister JR Grandis 2006 Head and neck cancer: recent advances and new standards of care J Clin Oncol 24 17 2603 2605 (Pubitemid 46622079)
11. RE Hillman MJ Walsh GT Wolf SG Fisher WK Hong 1998 Functional outcomes following treatment for advanced laryngeal cancer. Part I-voice preservation in advanced laryngeal cancer. Part II-laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group Ann Otol Rhinol Laryngol Suppl 172 1 27
12. ML Hinni JR Salassa DG Grant BW Pearson RE Hayden A Martin H Christiansen BH Haughey B Nussenbaum W Steiner 2007 Transoral laser microsurgery for advanced laryngeal cancer Arch Otolaryngol Head Neck Surg 133 12 1198 1204 (Pubitemid 350294247)
13. HT Hoffman K Porter LH Karnell JS Cooper RS Weber CJ Langer KK Ang G Gay A Stewart RA Robinson 2006 Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival Laryngoscope 116 9 1529 1542
14. R Knecht M Baghi M Hambek H Tesch W Gstottner 2003 Response rate and outcome of a novel induction chemotherapy regimen (TPF) in the first-line therapy of advanced head and neck carcinomas (SCCHN) Proc Am Soc Clin Oncol 22 501 (abstract 2017)
15. JL Lefebvre D Chevalier B Luboinski A Kirkpatrick L Collette T Sahmoud 1996 Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 890 899 (Pubitemid 26230640)
16. L Pfreundner F Hoppe J Willner V Preisler K Bratengeier R Hagen J Helms M Flentje 2003 Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas-a possibility for organ preservation Radiother Oncol 68 163 170 (Pubitemid 38367549)
17. JP Pignon J Bourhis C Domenge L Designe 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 949 955
18. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI (2007) TAX 324 Study Group. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 25;357(17):1705-1715 (Pubitemid 350005152)
19. DI Rosenthal JS Lewin A Eisbruch 2006 Dysphagia after radiation therapy or chemoradiation for head and neck cancer J Clin Oncol 24 2636 2643
20. P Rubin LS Constine LF Fajardo TL Phillips TH Wasserman 1995 RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system Int J Radiat Oncol Biol Phys 31 5 1041 1042
21. S Staar V Rudat H Stuetzer A Dietz P Volling M Schroeder M Flentje HE Eckel RP Mueller 2001 Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: Results of a multcentric randomized German trial in advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 50 1161 1171 (Pubitemid 32727792)
22. The Department of Veterans Affairs Laryngeal Cancer Study Group 1991 Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1685 1690
23. A Trotti SM Bentzen 2004 The need for adverse effects reporting standards in oncology clinical trials J Clin Oncol 22 1 19 22 (Pubitemid 41095109)
24. S Urba G Wolf A Eisbruch F Worden J Lee C Bradford T Teknos D Chepeha M Prince N Hogikyan J Taylor 2006 Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm J Clin Oncol 24 4 593 598 (Pubitemid 46630421)
25. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, van den Weyngaert D, Awada A, Cupissol D, Kienzer HR, Rey A, Desaunois I, Bernier J, Lefebvre JL (2007) EORTC 24971/TAX 323 Study Group. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 25;357(17):1695-1704
26. J Willner K Baier L Pfreundner M Flentje 1999 Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma Acta Oncol 38 1025 1030 (Pubitemid 30033024)